title: Blood pressure control in hypertensive patients in Irish primary care practices.
abstract: In Ireland, cardiovascular disease is a major cause of death. However, blood pressure (BP) goal achievement is unsatisfactory. The authors aimed to document BP control and increase awareness. A total of 1534 patients were enrolled in the study, with a mean age of 64.7+/-11.9 years (53.8% women). Duration of hypertension was 8.7+/-7.7 years, and 14.6% had diabetes, 13.8% had coronary artery disease, and 40.5% were taking antihypertensive monotherapy. beta-Blockers (39.8%), angiotensin-converting enzyme inhibitors (32.2%), and angiotensin receptor blockers (22.0%) were prescribed most frequently. Mean BP was 136.0+/-6.1 mm Hg/89.5+/-5.0 mm Hg in nondiabetic patients (48.6% <140/90 mm Hg) and 131.0+/-7.4 mm Hg/81.7+/-4.6 mm Hg in diabetic patients (16.7% <130/80 mm Hg). Diet, exercise, and lifestyle modifications (63.5%) were frequently recommended. Increased patient awareness and compliance together with the adherence of physicians to current guidelines and greater willingness to take action in patients with uncontrolled hypertension should help in improving BP control and thus reduce cardiovascular risk.
authors.affiliation: European Centre for Clinical Trials in Rare Diseases, University College Cork, Cork, Ireland. b.buckley@ucc.ie
authors.forename: Brendan
authors.initials: B
authors.lastname: Buckley
authors.forename: Eamonn
authors.initials: E
authors.lastname: Shanahan
authors.forename: Niall
authors.initials: N
authors.lastname: Colwell
authors.forename: Eva
authors.initials: E
authors.lastname: Turgonyi
authors.forename: Peter
authors.initials: P
authors.lastname: Bramlage
authors.forename: Ivan J
authors.initials: IJ
authors.lastname: Perry
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000368:Aged; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001794:Blood Pressure / Q000502:physiology*; D003131:Combined Modality Therapy; D004035:Diet Therapy; D005081:Exercise Therapy; D005260:Female; D006306:Health Surveys; D006801:Humans; D006973:Hypertension / Q000453:epidemiology / Q000503:physiopathology* / Q000628:therapy*; D007494:Ireland / Q000453:epidemiology; D008019:Life Style; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D011320:Primary Health Care; D016896:Treatment Outcome
chemical_list: D000319:Adrenergic beta-Antagonists; D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents
references.citation: BMJ. 2001 Mar 3;322(7285):531-6
references.pmid: 11230071
references.citation: Ann Intern Med. 2001 Nov 6;135(9):825-34
references.pmid: 11694107
references.citation: Circulation. 2006 Jan 17;113(2):213-21
references.pmid: 16391156
references.citation: BMJ. 2004 Mar 13;328(7440):634-40
references.pmid: 15016698
references.citation: Arch Intern Med. 2002 Feb 25;162(4):413-20
references.pmid: 11863473
references.citation: J Clin Hypertens (Greenwich). 2009 Jan;11(1):1-4
references.pmid: 19125851
references.citation: Ir Med J. 2002 Nov-Dec;95(10):298-301
references.pmid: 12542011
references.citation: Lancet. 2002 Dec 14;360(9349):1903-13
references.pmid: 12493255
references.citation: J Hum Hypertens. 2006 Dec;20(12):917-22
references.pmid: 16988753
references.citation: Ger Med Sci. 2006 Oct 09;4:Doc07
references.pmid: 19675698
references.citation: J Hypertens. 2004 Mar;22(3):479-86
references.pmid: 15076152
references.citation: Curr Med Res Opin. 2007 Apr;23(4):783-91
references.pmid: 17407635
references.citation: J Hypertens. 2004 Jan;22(1):11-9
references.pmid: 15106785
references.citation: J Epidemiol Community Health. 2006 Apr;60(4):322-7
references.pmid: 16537349
references.citation: Blood Press Monit. 2002 Apr;7(2):135-42
references.pmid: 12048432
references.citation: Eur Heart J. 1995 Jun;16(6):752-60
references.pmid: 7588918
references.citation: JAMA. 2003 May 14;289(18):2363-9
references.pmid: 12746359
references.citation: J Clin Hypertens (Greenwich). 2007 May;9(5):316-23
references.pmid: 17485966
references.citation: J Hypertens. 2007 Jun;25(6):1105-87
references.pmid: 17563527
references.citation: J Am Coll Cardiol. 2007 Aug 14;50(7):563-72
references.pmid: 17692739
references.citation: JAMA. 2003 May 21;289(19):2560-72
references.pmid: 12748199
references.citation: Lancet. 2006 May 27;367(9524):1747-57
references.pmid: 16731270
references.citation: Am J Hypertens. 1998 Apr;11(4 Pt 1):445-53
references.pmid: 9607383